CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00291-06v1
13/12/1343    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sopp, P.
Right arrow Articles by Hope, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sopp, P.
Right arrow Articles by Hope, J. C.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, December 2006, p. 1343-1348, Vol. 13, No. 12
1071-412X/06/$08.00+0     doi:10.1128/CVI.00291-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Flow Cytometric Detection of Gamma Interferon Can Effectively Discriminate Mycobacterium bovis BCG-Vaccinated Cattle from M. bovis-Infected Cattle{triangledown}

P. Sopp, C. J. Howard, and J. C. Hope*

Institute for Animal Health, Compton, Newbury, Berkshire RG207NN, United Kingdom

Received 17 August 2006/ Returned for modification 18 September 2006/ Accepted 19 September 2006

Mycobacterium bovis is the causative agent of bovine tuberculosis, a disease that is increasing in incidence in United Kingdom cattle herds. In addition to increasing economic losses, the rise in bovine tuberculosis poses a human health risk. There is an urgent requirement for effective strategies for disease eradication; this will likely involve vaccination in conjunction with current test and slaughter policies. A policy involving vaccination would require an accurate diagnosis of M. bovis-infected animals and the potential to distinguish these animals from vaccinates. Currently used diagnostic tests, the skin test and gamma interferon (IFN-{gamma}) blood test, have a sensitivity of up to 95%. A further complication is that M. bovis BCG-vaccinated animals are also scored positive by these tests. We tested the hypothesis that the quantification of IFN-{gamma}-producing lymphocytes by flow cytometric analysis of intracellular IFN-{gamma} expression would provide a more accurate discrimination of M. bovis-infected animals from BCG vaccinates. Significant numbers of IFN-{gamma}-expressing CD4+ T cells were detected following culture of heparinized blood from M. bovis-infected animals, but not from BCG vaccinates, with purified protein derived from M. bovis (PPD-B) or live mycobacteria. Only 1 of 17 BCG-vaccinated animals had a significant number of CD4+ T lymphocytes expressing IFN-{gamma}, compared with 21/22 M. bovis-infected animals. This assay could allow an accurate diagnosis of M. bovis and allow the discrimination of BCG-vaccinated cattle from infected cattle.


* Corresponding author. Mailing address: Institute for Animal Health, Compton, Newbury, Berkshire RG207NN, United Kingdom. Phone: 01635 577292. Fax: 01635 577263. E-mail: jayne.hope{at}BBSRC.ac.uk.

{triangledown} Published ahead of print on 27 September 2006.


Clinical and Vaccine Immunology, December 2006, p. 1343-1348, Vol. 13, No. 12
1071-412X/06/$08.00+0     doi:10.1128/CVI.00291-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.